FTC slams pharmacy benefit managers in first report from ongoing investigation | Healthcare Dive
The report is not positive for the drug middlemen, which immediately criticized it as one-sided.| Healthcare Dive
The report is not positive for the drug middlemen, which immediately criticized it as one-sided.| Healthcare Dive
FTC: ‘Big 3’ Pharmacy Benefit Managers Engaged in Price Gouging, PBMs, UnitedHealth OptumRx, CVS Caremark Rx, Express Scripts| Campus Safety Magazine
FTC released an interim report criticizing the negative impact pharmacy benefit manager (PBMs) have on prescription drug prices and access.| Bio.News
4% of all the money in America flows through a few mafia-like health care conglomerates. The FTC just released a ground-breaking report on how they operate. And it is gearing up to sue.| www.thebignewsletter.com
